117 related articles for article (PubMed ID: 33667841)
21. Maternal DOT1L is dispensable for mouse development.
Liao J; Szabó PE
Sci Rep; 2020 Nov; 10(1):20636. PubMed ID: 33244015
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic priming by Dot1l in lymphatic endothelial progenitors ensures normal lymphatic development and function.
Yoo H; Lee YJ; Park C; Son D; Choi DY; Park JH; Choi HJ; La HW; Choi YJ; Moon EH; Saur D; Chung HM; Song H; Do JT; Jang H; Lee DR; Park C; Lee OH; Cho SG; Hong SH; Kong G; Kim JH; Choi Y; Hong K
Cell Death Dis; 2020 Jan; 11(1):14. PubMed ID: 31908356
[TBL] [Abstract][Full Text] [Related]
23. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
Lin X; Huang Y; Zou Y; Chen X; Ma X
Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761
[TBL] [Abstract][Full Text] [Related]
24. DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment.
Sarno F; Nebbioso A; Altucci L
Epigenetics; 2020 May; 15(5):439-453. PubMed ID: 31790636
[TBL] [Abstract][Full Text] [Related]
25. DOT1L histone methyltransferase regulates the expression of BCAT1 and is involved in sphere formation and cell migration of breast cancer cell lines.
Oktyabri D; Ishimura A; Tange S; Terashima M; Suzuki T
Biochimie; 2016 Apr; 123():20-31. PubMed ID: 26783998
[TBL] [Abstract][Full Text] [Related]
26. Histone Methyltransferase hSETD1A Is a Novel Regulator of Metastasis in Breast Cancer.
Salz T; Deng C; Pampo C; Siemann D; Qiu Y; Brown K; Huang S
Mol Cancer Res; 2015 Mar; 13(3):461-9. PubMed ID: 25373480
[TBL] [Abstract][Full Text] [Related]
27. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
[TBL] [Abstract][Full Text] [Related]
28. Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation.
Aslam MA; Alemdehy MF; Kwesi-Maliepaard EM; Muhaimin FI; Caganova M; Pardieck IN; van den Brand T; van Welsem T; de Rink I; Song JY; de Wit E; Arens R; Jacobs H; van Leeuwen F
EMBO Rep; 2021 Feb; 22(2):e51184. PubMed ID: 33410591
[TBL] [Abstract][Full Text] [Related]
29. Histone methyltransferase Dot1L inhibits pancreatic cancer cell apoptosis by promoting NUPR1 expression.
Shan L; Hao C; Jun Z; Qinghe C
J Int Med Res; 2022 Mar; 50(3):3000605221088431. PubMed ID: 35350907
[TBL] [Abstract][Full Text] [Related]
30. Hesperetin reverses P‑glycoprotein‑mediated cisplatin resistance in DDP‑resistant human lung cancer cells via modulation of the nuclear factor‑κB signaling pathway.
Kong W; Ling X; Chen Y; Wu X; Zhao Z; Wang W; Wang S; Lai G; Yu Z
Int J Mol Med; 2020 Apr; 45(4):1213-1224. PubMed ID: 32124932
[TBL] [Abstract][Full Text] [Related]
31. RE-IIBP Methylates H3K79 and Induces MEIS1-mediated Apoptosis via H2BK120 Ubiquitination by RNF20.
Woo Park J; Kim KB; Kim JY; Chae YC; Jeong OS; Seo SB
Sci Rep; 2015 Jul; 5():12485. PubMed ID: 26206755
[TBL] [Abstract][Full Text] [Related]
32. Targeting Histone Methylation in Cancer.
McCabe MT; Mohammad HP; Barbash O; Kruger RG
Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430
[TBL] [Abstract][Full Text] [Related]
33. Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond.
Chen CW; Armstrong SA
Exp Hematol; 2015 Aug; 43(8):673-84. PubMed ID: 26118503
[TBL] [Abstract][Full Text] [Related]
34. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
35. The histone methyltransferase DOT1L: regulatory functions and a cancer therapy target.
Wong M; Polly P; Liu T
Am J Cancer Res; 2015; 5(9):2823-37. PubMed ID: 26609488
[TBL] [Abstract][Full Text] [Related]
36. Peperomin E Induces Promoter Hypomethylation of Metastatic-Suppressor Genes and Attenuates Metastasis in Poorly Differentiated Gastric Cancer.
Wanga XZ; Gu JL; Gao M; Bian Y; Liang JY; Wen HM; Wu H
Cell Physiol Biochem; 2018; 50(6):2341-2364. PubMed ID: 30423554
[TBL] [Abstract][Full Text] [Related]
37. A novel role of DOT1L in kidney diseases.
Wei W; Zhao Y; Chai Y; Shou S; Jin H
Mol Biol Rep; 2023 Jun; 50(6):5415-5423. PubMed ID: 37085741
[TBL] [Abstract][Full Text] [Related]
38. Depletion of H3K79 methyltransferase Dot1L promotes cell invasion and cancer stem-like cell property in ovarian cancer.
Wang X; Wang H; Xu B; Jiang D; Huang S; Yu H; Wu Z; Wu Q
Am J Transl Res; 2019; 11(2):1145-1153. PubMed ID: 30899413
[TBL] [Abstract][Full Text] [Related]
39. DOT1L Activity Promotes Proliferation and Protects Cortical Neural Stem Cells from Activation of ATF4-DDIT3-Mediated ER Stress In Vitro.
Roidl D; Hellbach N; Bovio PP; Villarreal A; Heidrich S; Nestel S; Grüning BA; Boenisch U; Vogel T
Stem Cells; 2016 Jan; 34(1):233-45. PubMed ID: 26299268
[TBL] [Abstract][Full Text] [Related]
40. Structural basis of recognition and destabilization of the histone H2B ubiquitinated nucleosome by the DOT1L histone H3 Lys79 methyltransferase.
Jang S; Kang C; Yang HS; Jung T; Hebert H; Chung KY; Kim SJ; Hohng S; Song JJ
Genes Dev; 2019 Jun; 33(11-12):620-625. PubMed ID: 30923167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
